De Facto expands into med ed

pharmafile | November 17, 2005 | News story | Medical Communications |   

PR firm De Facto has launched a medical education arm and signed up its first two clients for the new part of the business.

De Facto Medica will offer a wide range of med ed services to biotechs, big pharma and medical device companies and is headed up by chief executive Richard Anderson and director Marcel Kay.

"The PR side of De Facto has traditionally offered elements of med ed and with De Facto Medica we're trying to build a continuity of service and produce communications that offer a new way of thinking," Kay said.

Advertisement

Within a week of setting up, De Facto Medica won two accounts – both are European companies, one pharma and one a biotech, and only one of them was an existing client.

Kay said De Facto Medica is in the process of pitching for several pieces of new business and hopes to take on more staff next year.

For now the company can draw on a seven-strong team that includes medical writers, copywriters and the medical communications specialists Mel Edrich and Shairose Ebrahim.

Ebrahim was formerly a marketing manager at Merck, Sharp & Dohme for Zocor and Innovace and will work with De Facto Medica on an as-needed basis from Zaebra Consulting.

De Facto was acquired in September by Chime, joining the communications groups other healthcare business Ozone with an expectation the two businesses would work closely together.

Related articles:

Renamed agency takes on OTC Zocor account  

Monday , March 01, 2004

 

 

 

Related Content

No items found
The Gateway to Local Adoption Series

Latest content